Diagnosis of VTE postdischarge for major abdominal and pelvic oncologic surgery: Implications for a change in practice

Canadian Journal of Surgery

Volumn 58, Issue 5, 2015, Pages 305-311

  Alsubaie, Hamad ^a   Leggett, Carly ^b   Lambert, Pascal ^b   Park, Jason ^a,b   Hochman, David ^a   Wirtzfeld, Debrah ^b   McKay, Andrew ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CancerCare   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL NEOPLASMS; ADULT; ADVERSE EFFECTS; AGED; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; MANITOBA; MIDDLE AGED; PELVIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; REGISTER; STATISTICS AND NUMERICAL DATA; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MANITOBA; MIDDLE AGED; PATIENT DISCHARGE; PELVIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOEMBOLISM;

EID: 84943794551     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.012314     Document Type: Article

References (28)

1. Huse DM, Cummins G, Taylor DC, et al. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Am J Manag Care 2002;8(Suppl):S10-6.
2. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(Suppl):338S-400S.
3. Negus JJ, Gardner JJ, Tann O, et al. Thromboprophylaxis in major abdominal surgery for cancer. Eur J Surg Oncol 2006;32:911-6.
4. Galster H, Kolb G, Kohsytorz A, et al. The pre-, peri-, and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res 2000;100:381-8.
5. Rasmussen MS. Prolonged thromboprophylaxis with low molecular weight heparin after major abdominal surgery. Curr Opin Pulm Med 2007;13:389-92.
6. Scurr JH, Coleridge-Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. BMJ 1988;297:28.
7. Sôrensen C, Andersen M, Kristiansen VB, et al. The occurrence of late thromboembolic complications after elective abdominal surgery. Ugeskr Laeger 1990;152:1586-7.
8. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 2006;4:2384-90.
9. Bergqvist D. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis. J Surg Oncol 2007;95:167-74.
10. Negus JJ, Gardner JJ, Tann O, et al. Thromboprophylaxis in major abdominal surgery for cancer. Eur J Surg Oncol 2006;32:911-6.
11. Rasmussen MS, Wille-Jorgensen P, Jorgensen LN. Postoperative fatal pulmonary embolism in a general surgical department. Am J Surg 1995;169:214-6.
12. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-80.
13. Lausen I, Jensen R, Jorgensen LN, et al. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis. Eur J Surg 1998;164:657-63.
14. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2009;(1)(1):CD004318.
15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
16. The Johns Hopkins University ACG case-mix Adjustment System [computer program]. Johns hopkins university school of hygiene and public health.version 9.0. baltimore, MD: Johns hopkins university, 2012.
17. th ed. New York, Springer-Verlag, 2002.
18. Merkow RP, Bilimoria KY, McCarter MD, et al. Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg 2011;254:131-7.
19. Fleming FJ, Kim MJ, Salloum RM, et al. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the national surgical quality improvement program database. Dis Colon Rectum 2010;53:1355-60.
20. Jorgensen LN, Lausen I, Rasmussen MS, et al. Prolonged thromboprophylaxis with low-molecular weight heparin following major general surgery: an individual patient data meta-analysis. Blood 2002;100.
21. Raftopoulos I, Martindale C, Cronin A, et al. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc 2008;22:2384-91.
22. th ed: American college of chest physicians evidencebased clinical practice guidelines. Chest 2012;141:e227S-77S.
23. Bahl V, Jacob P III, Havel C, et al. Thirdhand cigarette smoke: factors affecting exposure and remediation. PLoS ONE 2014;9:e108258.
24. Spyropoulos AC, Hussein M, Lin J, et al. Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost 2009;102:951-7.
25. Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010;? 251:344-50.
26. th edition). Chest 2008;133(6 Suppl):381S-453S.
27. Wright JD, Lewin SN, Shah M, et al. Quality of venous thromboembolism prophylaxis in patients undergoing oncologic surgery. Ann Surg 2011;253:1140-6.
28. Auer R, Scheer A, Wells PS, et al. The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer: a pilot randomized controlled trial. Blood Coagul Fibrinolysis 2011;22:760-2.